| Domain | Rank | Visitors | Earning per month | Valuation |
| dtxplatform.com | 432612 | 45 | 5$ | 150$ |
| dtxexplained.com | None | 11$ | 330$ | |
| dtxeurope.com | None | 0 | 0$ | 1000$ |
| smartpatient.eu | None | 508 | 94$ | 2820$ |
| techtomed.com | None | 0 | 25$ | 750$ |
| btc-alpha.com | 773367 | 695 | 78$ | 2340$ |
| alp.com | 3444645 | 8,769 | 816$ | 24480$ |
| lockmeta.com | 479945 | 94,800 | 9,698$ | 290940$ |
| Moz Backlinks Count | 121 |
| Moz Page Rank | 3 |
| Domain Authority (DA) | 22.0 |
| Page Authority (PA) | 33.0 |
| Country | Rank | Pct |
|---|
| Country Name | Unknown |
| Daily unique visits | 245 |
| Daily Page Views | 490 |
| Income Per Day | 46 USD |
| Alextherapeutics.com valuation | 1380 |
| Type | Status |
| HTML 5 | 
|
| Responsive Website | 
|
| No | Text |
| 1 | Personalized digital solutions for patients and their treatment challenges. |
| 2 | Delivering evidence-based solutions that improve patient outcomes. |
| 3 | Improve patient outcomes with digital companions proven to change behavior. |
| No | Text |
| 1 | How Vicore Pharma and Alex Therapeutics partnered to build Almee™ - a digital therapy to treat anxiety for patients with pulmonary fibrosis |
| 2 | Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Therapy for Anxiety |
| 3 | Empowering patients to manage their treatment effectively. |
| 4 | Deliver engaging digital therapies that are evidence-based and clinically proven. |
| 5 | How CBT can be applied across different indications |
| 6 | Almee™ Receives Breakthrough Device Designation From the FDA |
| 7 | What is the Access to Prescription Digital Therapeutics Act? |
| 8 | Sign up for our industry insights |
| Social | Count |
| Facebook Likes | 0 |
| Reddit score | 0 |
| Pinterest Share Count | 0 |
| Vk Share Count | 0 |
| OK Share Count | 0 |